Starbucks coffee in California must have cancer warning, judge says

March 29 (Reuters) - Starbucks Corp and other coffee sellers must put a cancer warning on coffee sold in California, a Los Angeles judge has ruled, possibly exposing the companies to millions of dollars in fines.

A little-known not-for-profit group sued some 90 coffee retailers, including Starbucks, on grounds they were violating a California law requiring companies to warn consumers of chemicals in their products that could cause cancer.

One of those chemicals is acrylamide, a byproduct of roasting coffee beans that is present in high levels in brewed coffee.

Los Angeles Superior Court Judge Elihu Berle said in a decision dated Wednesday that Starbucks and other companies had failed to show there was no significant risk from a carcinogen produced in the coffee roasting process, court documents showed.

SEE ALSO: Compound found in asparagus linked to spread of breast cancer

Starbucks and other defendants have until April 10 to file objections to the decision.

Starbucks declined to comment, referring reporters to a statement by the National Coffee Association (NCA) that said the industry was considering an appeal and further legal actions.

"Cancer warning labels on coffee would be misleading. The U.S. government’s own Dietary Guidelines state that coffee can be part of a healthy lifestyle," the NCA statement said.

In his decision, Berle said: "Defendants failed to satisfy their burden of proving by a preponderance of evidence that consumption of coffee confers a benefit to human health."

Officials from Dunkin’ Donuts, McDonald's Corp , Peet's and other big coffee sellers did not immediately respond to requests for comment.

More on coffee competitors:

10 PHOTOS
10 coffee chains predicted to be the next Starbucks
See Gallery
10 coffee chains predicted to be the next Starbucks

Joe Coffee

Number of locations: 16

States: New York, Pennsylvania

Photo credit: Facebook

Colectivo Coffee Roasters

Number of locations: 17

States: Washington, Illinois

Kaldi's Coffee

Number of locations: 18

States: Missouri, Georgia

Thomas Hammer Coffee Roasters

Number of locations: 18

States: Washington, Idaho

Woods Coffee

Number of locations: 19

States: Washington

Gregorys Coffee

Number of locations: 26

States: New York, New Jersey

La Colombe Coffee Roasters

Number of locations: 26

States: New York, Pennsylvania, Illinois, Washington D.C.

Blue Bottle Coffee Company

Number of locations: 35

States: California, New York, Washington D.C.

Philz Coffee

Number of locations: 40

States: California, Washington D.C.

Black Rock Coffee Bar

Number of locations: 42

States: Oregon, Washington, Arizona, Idaho, California

HIDE CAPTION
SHOW CAPTION
of
SEE ALL
BACK TO SLIDE

The lawsuit was filed in 2010 by the Council for Education and Research on Toxics (CERT). It calls for fines as large as $2,500 per person for every exposure to the chemical since 2002 at the defendants’ shops in California. Any civil penalties, which will be decided in a third phase of the trial, could be huge in California, which has a population of nearly 40 million.

CERT's lawyer Raphael Metzger did not immediately respond to a request for comment.

Starbucks lost the first phase of the trial in which it failed to show the level of acrylamide in coffee was below that which would pose a significant risk of cancer. In the second phase of the trial, defendants failed to prove there was an acceptable "alternative" risk level for the carcinogen, court documents showed.

Several defendants in the case settled before Wednesday's decision, agreeing to post signage about the cancer-linked chemical and pay millions in fines, according to published reports. (Reporting by Nate Raymond; Additional reporting by Lisa Baertlein Writing by Andrew Hay Editing by Richard Chang and Leslie Adler)

Read Full Story

Sign up for Breaking News by AOL to get the latest breaking news alerts and updates delivered straight to your inbox.

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.